$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

$bkyi Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000143774924019357 Filed on June 05, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$1.141M	$925.1K	$7.755M
YoY Change	-40.83%	-47.39%	10.46%
Cost Of Revenue	$262.3K	$4.421M	$6.324M
YoY Change	-56.73%	656.45%	210.05%
Gross Profit	$879.0K	-$3.496M	$1.431M
YoY Change	-33.55%	-397.74%	-71.26%
Gross Profit Margin	77.02%	-377.85%	18.46%
Selling, General & Admin	$1.942M	$2.440M	$7.863M
YoY Change	-0.07%	-26.65%	-18.46%
% of Gross Profit	220.91%		549.33%
Research & Development	$591.2K	$587.9K	$2.395M
YoY Change	5.92%	-29.46%	-26.36%
% of Gross Profit	67.26%		167.32%
Depreciation & Amortization	$100.2K	$173.5K	$75.14K
YoY Change	6.17%	23.9%	71.57%
% of Gross Profit	11.39%		5.25%
Operating Expenses	$2.533M	$3.028M	$10.26M
YoY Change	1.27%	-27.21%	-20.45%
Operating Profit	-$1.654M	-$6.524M	-$8.826M
YoY Change	40.35%	118.46%	11.53%
Interest Expense	-$12.86K	$54.20K	$218.3K
YoY Change	-122.64%	-115.58%	-140.33%
% of Operating Profit
Other Income/Expense, Net	-$12.86K		$170.5K
YoY Change	-87.31%		-108.49%
Pretax Income	-$1.667M	-$6.450M	-$8.656M
YoY Change	30.24%	26.2%	-15.4%
Income Tax	$0.00	-$276.8K	-$134.0K
% Of Pretax Income
Net Earnings	-$1.667M	-$6.173M	-$8.522M
YoY Change	17.15%	20.79%	-16.71%
Net Earnings / Revenue	-146.06%	-667.26%	-109.89%
Basic Earnings Per Share	-$1.00		-$15.21
Diluted Earnings Per Share	-$1.00	-$8.41	-$15.21
COMMON SHARES
Basic Shares Outstanding	1.814M	13.73M	560.3K
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.260M	$511.4K	$511.4K
YoY Change	122.87%	-80.6%	-80.6%
Cash & Equivalents	$1.260M	$511.4K	$511.4K
Short-Term Investments
Other Short-Term Assets	$28.16K	$99.32K	$364.2K
YoY Change	-62.07%	-69.63%	11.35%
Inventory	$433.2K	$445.7K	$445.7K
Prepaid Expenses
Receivables	$904.0K	$1.202M	$1.202M
Other Receivables	$28.16K	$99.32K	$99.32K
Total Short-Term Assets	$3.015M	$2.622M	$2.622M
YoY Change	-64.67%	-72.01%	-72.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$174.4K	$220.2K	$257.1K
YoY Change	115.19%	-27.76%	-15.65%
Goodwill
YoY Change
Intangibles	$1.252M	$1.408M
YoY Change	-21.75%	-20.13%
Long-Term Investments
YoY Change
Other Assets	$348.6K	$229.8K	$229.8K
YoY Change	21.83%	-21.24%	-21.24%
Total Long-Term Assets	$1.784M	$1.895M	$1.895M
YoY Change	-13.03%	-25.52%	-25.52%
TOTAL ASSETS
Total Short-Term Assets	$3.015M	$2.622M	$2.622M
Total Long-Term Assets	$1.784M	$1.895M	$1.895M
Total Assets	$4.799M	$4.517M	$4.517M
YoY Change	-54.65%	-62.08%	-62.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.540M	$1.316M	$1.316M
YoY Change	-17.05%	18.74%	18.74%
Accrued Expenses	$1.165M	$1.306M	$1.344M
YoY Change	29.28%	11.73%	14.96%
Deferred Revenue	$715.2K	$415.0K
YoY Change	9.74%	-10.26%
Short-Term Debt	$2.010M	$0.00	$0.00
YoY Change	-19.55%	-100.0%	-100.0%
Long-Term Debt Due	$135.4K	$138.7K	$138.7K
YoY Change	0.07%	-57.55%	-57.55%
Total Short-Term Liabilities	$5.575M	$3.213M	$3.213M
YoY Change	-11.18%	-30.8%	-30.8%
LONG-TERM LIABILITIES
Long-Term Debt	$114.7K	$188.8K	$188.8K
YoY Change	-55.08%	57.32%	57.33%
Other Long-Term Liabilities	$143.0K	$28.30K	$28.30K
YoY Change	205.12%	-68.54%	-68.54%
Total Long-Term Liabilities	$280.6K	$240.1K	$217.1K
YoY Change	-39.27%	14.35%	3.4%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.575M	$3.213M	$3.213M
Total Long-Term Liabilities	$280.6K	$240.1K	$217.1K
Total Liabilities	$5.855M	$3.453M	$3.453M
YoY Change	-13.1%	-28.84%	-28.84%
SHAREHOLDERS EQUITY
Retained Earnings	-$127.2M	-$125.0M
YoY Change	7.6%	7.32%
Common Stock	$182.00	$103.00
YoY Change	-80.35%	-88.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.056M	$1.064M	$1.064M
YoY Change
Total Liabilities & Shareholders Equity	$4.799M	$4.517M	$4.517M
YoY Change	-54.65%	-62.08%	-62.08%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$1.667M	-$6.173M	-$8.522M
YoY Change	17.15%	20.79%	-16.71%
Depreciation, Depletion And Amortization	$100.2K	$173.5K	$75.14K
YoY Change	6.17%	23.9%	71.57%
Cash From Operating Activities	-$1.421M	-$1.532M	-$3.793M
YoY Change	753.83%	-19.42%	-39.1%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$1.000K	$1.000K
YoY Change		-98.04%	-98.78%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	$0.00	-$1.000K	-$1.000K
YoY Change		-99.41%	-99.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.966M	1.559M	$1.433M
YoY Change	-24617.46%	-18.1%	-24.68%
NET CHANGE
Cash From Operating Activities	-1.421M	-1.532M	-$3.793M
Cash From Investing Activities	0.000	-1.000K	-$1.000K
Cash From Financing Activities	1.966M	1.559M	$1.433M
Net Change In Cash	545.7K	26.29K	-$2.124M
YoY Change	-412.9%	-115.7%	-58.5%
FREE CASH FLOW
Cash From Operating Activities	-$1.421M	-$1.532M	-$3.793M
Capital Expenditures	$0.00	$1.000K	$1.000K
Free Cash Flow	-$1.421M	-$1.533M	-$3.794M
YoY Change	753.83%	-21.47%	-39.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1032777
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1032777
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	552739
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	552739
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	729905	usd
CY2021Q4	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P4Y
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7020258	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd
CY2022Q4	bkyi	Software License Rights SoftwareLicenseRights	0	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.025	pure
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	1-13463
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1741861
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	101 CRAWFORDS CORNER ROAD, SUITE 4116
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	HOLMDEL
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07753
CY2023	dei	City Area Code CityAreaCode	732
CY2023	dei	Local Phone Number LocalPhoneNumber	359-1100
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2023	dei	Trading Symbol TradingSymbol	BKYI
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	6303798	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1814228
CY2023	dei	Auditor Name AuditorName	Bush and Associates CPA
CY2023	dei	Auditor Firm AuditorFirmId	6797
CY2023	dei	Auditor Location AuditorLocation	Henderson, Nevada
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	511400	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2635522	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1201526	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1522784	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	99320	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	49500	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	445740	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	4434369	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	364171	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	342706	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2622157	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	8984881	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	220177	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	107413	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	229806	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	283069	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	0	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	36905	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	197355	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1407990	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1762825	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1894878	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2359374	usd
CY2023Q4	us-gaap	Assets Assets	4517035	usd
CY2022Q4	us-gaap	Assets Assets	11344255	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1316014	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1108279	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1305848	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1009123	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	2596203	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	138730	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	120000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	414968	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	462418	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	37829	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	159665	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3213389	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5455688	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	28296	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	52134	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	22998	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	170281	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	188787	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	326767	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	37829	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	240081	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	587011	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3453470	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6042699	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	103	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	55	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	126047851	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	122029476	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	22821	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-242602	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-125007210	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116485373	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1063565	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5301556	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4517035	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11344255	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7754905	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7020258	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6323586	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2439570	usd
CY2023	us-gaap	Gross Profit GrossProfit	1431319	usd
CY2022	us-gaap	Gross Profit GrossProfit	4580688	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7862710	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9364887	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2394926	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3252236	usd
CY2023	bkyi	Business Combination Reversal Of Earnout Payable BusinessCombinationReversalOfEarnoutPayable	-0	usd
CY2022	bkyi	Business Combination Reversal Of Earnout Payable BusinessCombinationReversalOfEarnoutPayable	500000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2387193	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	10257636	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	14504316	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-8826317	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-9923628	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	11533	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	233	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	20000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-39000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	usd
CY2023	bkyi	Investment Income Debt Security Reserve Expense InvestmentIncomeDebtSecurityReserveExpense	-0	usd
CY2022	bkyi	Investment Income Debt Security Reserve Expense InvestmentIncomeDebtSecurityReserveExpense	452821	usd
CY2023	bkyi	Loan Transaction Costs LoanTransactionCosts	-0	usd
CY2022	bkyi	Loan Transaction Costs LoanTransactionCosts	1147456	usd
CY2023	bkyi	Fair Value Adjustment Of Convertible Note FairValueAdjustmentOfConvertibleNote	-396203	usd
CY2022	bkyi	Fair Value Adjustment Of Convertible Note FairValueAdjustmentOfConvertibleNote	396203	usd
CY2023	us-gaap	Interest Expense InterestExpense	218270	usd
CY2022	us-gaap	Interest Expense InterestExpense	10462	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	170466	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2006709	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8655851	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11930337	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-134014	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-20434	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-8521837	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11909903	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-8521837	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11909903	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	265423	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-242602	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8256414	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12152505	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-15.21
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-27.26
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	560278
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	436821
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	15615455	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	76043	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	-0	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	600003	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	700000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	94316	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	56380	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	18787	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-242602	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	293077	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11909903	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5301556	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	39007	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	3105	usd
CY2023	bkyi	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	320	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	3403322	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	892938	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	17478	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	4343	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	265423	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	225487	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	561367	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-8521837	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1063565	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-8521837	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11909903	usd
CY2023	us-gaap	Depreciation Depreciation	75136	usd
CY2022	us-gaap	Depreciation Depreciation	43794	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2387193	usd
CY2023	bkyi	Business Combination Reversal Of Earnout Payable BusinessCombinationReversalOfEarnoutPayable	-0	usd
CY2022	bkyi	Business Combination Reversal Of Earnout Payable BusinessCombinationReversalOfEarnoutPayable	500000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	354558	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	298113	usd
CY2023	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights	0	usd
CY2022	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights	48752	usd
CY2023	bkyi	Amortization Of Note Discount AmortizationOfNoteDiscount	0	usd
CY2022	bkyi	Amortization Of Note Discount AmortizationOfNoteDiscount	1147456	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-39000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-0	usd
CY2023	bkyi	Reserve For Investment Security ReserveForInvestmentSecurity	-0	usd
CY2022	bkyi	Reserve For Investment Security ReserveForInvestmentSecurity	-452821	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	3586500	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	400000	usd
CY2023	bkyi	Reserve For Note Receivable ReserveForNoteReceivable	-0	usd
CY2022	bkyi	Reserve For Note Receivable ReserveForNoteReceivable	-186000	usd
CY2023	bkyi	Provision For Doubtful Accounts Including Writeoff ProvisionForDoubtfulAccountsIncludingWriteoff	750000	usd
CY2022	bkyi	Provision For Doubtful Accounts Including Writeoff ProvisionForDoubtfulAccountsIncludingWriteoff	360000	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2023	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	171291	usd
CY2022	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	106624	usd
CY2023	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	226725	usd
CY2022	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	311864	usd
CY2023	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	39007	usd
CY2022	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	76043	usd
CY2023	bkyi	Allowance For Doubtful Accounts AllowanceForDoubtfulAccounts	-100000	usd
CY2022	bkyi	Allowance For Doubtful Accounts AllowanceForDoubtfulAccounts	-130111	usd
CY2023	bkyi	Fair Value Adjustment Of Convertible Note FairValueAdjustmentOfConvertibleNote	-396203	usd
CY2022	bkyi	Fair Value Adjustment Of Convertible Note FairValueAdjustmentOfConvertibleNote	396203	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-134014	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-20434	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	160449	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	155353	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	428742	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	339383	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	49820	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-0	usd
CY2023	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	118028	usd
CY2022	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	140681	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-402129	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-106291	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	21465	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	46655	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	57725	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	239144	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-121764	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	275561	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	167614	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-71288	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-120078	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-168376	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-165276	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3793456	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6229034	usd
CY2023	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	-0	usd
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	623578	usd
CY2023	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	usd
CY2022	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	9000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	82040	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-696618	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	4296260	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2200000	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	-0	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	320	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	561367	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	-0	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2002000	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	-0	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	155140	usd
CY2023	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-119251	usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	0	usd
CY2023	bkyi	Proceeds From Employee Stock Purchase Plan ProceedsFromEmployeeStockPurchasePlan	17478	usd
CY2022	bkyi	Proceeds From Employee Stock Purchase Plan ProceedsFromEmployeeStockPurchasePlan	56380	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1433440	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1903240	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	236894	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-96112	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2124122	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5118524	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2635522	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7754046	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	511400	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2635522	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	25682	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	218270	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	10462	usd
CY2023	bkyi	Business Combination Accounts Receivable Acquired BusinessCombinationAccountsReceivableAcquired	0	usd
CY2022	bkyi	Business Combination Accounts Receivable Acquired BusinessCombinationAccountsReceivableAcquired	702886	usd
CY2023	bkyi	Business Combination Equipment Acquired BusinessCombinationEquipmentAcquired	0	usd
CY2022	bkyi	Business Combination Equipment Acquired BusinessCombinationEquipmentAcquired	65640	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	0	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	20708	usd
CY2023	bkyi	Business Combination Intangible Assets Acquired BusinessCombinationIntangibleAssetsAcquired	0	usd
CY2022	bkyi	Business Combination Intangible Assets Acquired BusinessCombinationIntangibleAssetsAcquired	762860	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1258087	usd
CY2023Q4	bkyi	Noncash Or Part Noncash Acquisition Accrued Expenses And Other Liabilities Assumed NoncashOrPartNoncashAcquisitionAccruedExpensesAndOtherLiabilitiesAssumed	0	usd
CY2022Q4	bkyi	Noncash Or Part Noncash Acquisition Accrued Expenses And Other Liabilities Assumed NoncashOrPartNoncashAcquisitionAccruedExpensesAndOtherLiabilitiesAssumed	431884	usd
CY2023	bkyi	Noncash Or Part Noncash Acquisition Deferred Tax Liability NoncashOrPartNoncashAcquisitionDeferredTaxLiability	0	usd
CY2022	bkyi	Noncash Or Part Noncash Acquisition Deferred Tax Liability NoncashOrPartNoncashAcquisitionDeferredTaxLiability	190715	usd
CY2023Q4	bkyi	Noncash Or Part Noncash Acquisition Stock Issued Amount NoncashOrPartNoncashAcquisitionStockIssuedAmount	0	usd
CY2022Q4	bkyi	Noncash Or Part Noncash Acquisition Stock Issued Amount NoncashOrPartNoncashAcquisitionStockIssuedAmount	600004	usd
CY2023	bkyi	Stock Issued With Note Payable StockIssuedWithNotePayable	0	usd
CY2022	bkyi	Stock Issued With Note Payable StockIssuedWithNotePayable	700000	usd
CY2023	bkyi	Warrants Issued With Loan WarrantsIssuedWithLoan	0	usd
CY2022	bkyi	Warrants Issued With Loan WarrantsIssuedWithLoan	94316	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	105893	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	573785	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1201526	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt;"><em style="font: inherit;">2.</em> <i>Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 18pt;">Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) as set forth in the Financial Accounting Standards Board’s (FASB) Accounting Standards Codification (ASC) and consider the various staff accounting bulletins and other applicable guidance issued by the U.S. Securities and Exchange Commission (SEC). These accounting principles require us to make certain estimates, judgments and assumptions. The Company believes that the estimates, judgments and assumptions upon which it relies are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Certain significant accounting policies that contain subjective management estimates and assumptions include those related to accounts receivable, inventory, intangible assets and goodwill, fair value of convertible note payable, and income taxes.</p>
CY2021	bkyi	Percentage Of Support And Maintenance Revenue To License Cost PercentageOfSupportAndMaintenanceRevenueToLicenseCost	0.18	pure
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	443000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	515000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2207311	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2096569	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1005785	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1522784	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	573785	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-750000	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	318000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1005785	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	213785	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-360000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	-0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	573785	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	340000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	842000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3480	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	265732	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	387907	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2200000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2596203	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements	-2200000	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	396203	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7754905	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	467000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	489000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	443000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	515000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	326007	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	377958	usd
CY2023Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	327252	usd
CY2022Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	378874	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	264976	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2000000	usd
CY2020Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	295000	usd
	us-gaap	Receivable With Imputed Interest Effective Yield Interest Rate ReceivableWithImputedInterestEffectiveYieldInterestRate	0.05	pure
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	186000	usd
CY2022Q1	bkyi	Notes Receivable Periodic Payment NotesReceivablePeriodicPayment	1000	usd
CY2022Q3	bkyi	Notes Receivable Periodic Payment NotesReceivablePeriodicPayment	15000	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	0	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	195000	usd
CY2023Q4	bkyi	Repayments Of Notes Receivable RepaymentsOfNotesReceivable	-0	usd
CY2022Q4	bkyi	Repayments Of Notes Receivable RepaymentsOfNotesReceivable	9000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	-0	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	186000	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	0	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	0	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	0	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	0	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	0	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	0	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	110008	usd
CY2023Q4	bkyi	Accrued Franchise Taxes Current AccruedFranchiseTaxesCurrent	152986	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4373056	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4764643	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	59184	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	69726	usd
CY2023Q4	bkyi	Inventory Finished Goods Reserves InventoryFinishedGoodsReserves	3986500	usd
CY2022Q4	bkyi	Inventory Finished Goods Reserves InventoryFinishedGoodsReserves	400000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	445740	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	4434369	usd
CY2023	bkyi	Cumulative Amount Of Amortization Expense Net Of Credits CumulativeAmountOfAmortizationExpenseNetOfCredits	141190	usd
CY2023Q4	bkyi	Software License Rights SoftwareLicenseRights	0	usd
CY2022Q4	bkyi	Accrued Franchise Taxes Current AccruedFranchiseTaxesCurrent	7000	usd
CY2023Q4	bkyi	Accrued Employee Expenses Reimbursement Current AccruedEmployeeExpensesReimbursementCurrent	124209	usd
CY2022Q4	bkyi	Accrued Employee Expenses Reimbursement Current AccruedEmployeeExpensesReimbursementCurrent	114209	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	19282	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	17594	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	91136	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1322982	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1135082	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1102805	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1027669	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	220177	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	107413	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	75136	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	43794	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2607940	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2607940	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1199950	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	845115	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1407990	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1762825	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	223000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	141000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1305848	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1009123	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	166161	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	254649	usd
CY2023	us-gaap	Lease Cost LeaseCost	166161	usd
CY2022	us-gaap	Lease Cost LeaseCost	254649	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	37829	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	159665	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	37829	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y8M1D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y11M15D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055	pure
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	213783	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	259558	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	38808	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	38808	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	979	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	37829	usd
CY2023	bkyi	Weighted Average Exercise Price Warrants Expired WeightedAverageExercisePriceWarrantsExpired	0
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2626492
CY2023Q4	bkyi	Warrants Outstanding Exercise Price WarrantsOutstandingExercisePrice	19.09
CY2023	bkyi	Warrants Outstanding Weighted Average Remaining Life WarrantsOutstandingWeightedAverageRemainingLife	P4Y4M13D
CY2023Q4	us-gaap	Share Price SharePrice	3
CY2022Q4	us-gaap	Share Price SharePrice	10.62
CY2021Q4	us-gaap	Share Price SharePrice	39.78
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	260525
CY2021Q4	bkyi	Warrants Outstanding Exercise Price WarrantsOutstandingExercisePrice	106.42
CY2021	bkyi	Warrants Outstanding Weighted Average Remaining Life WarrantsOutstandingWeightedAverageRemainingLife	P3Y5M23D
CY2022	bkyi	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	11112
CY2022	bkyi	Weighted Average Exercise Price Warrants Granted WeightedAverageExercisePriceWarrantsGranted	54
CY2022	bkyi	Total Warrants Exercised TotalWarrantsExercised	-0
CY2022	bkyi	Weighted Average Exercise Price Warrants Exercised WeightedAverageExercisePriceWarrantsExercised	0
CY2022	bkyi	Total Warrants Forfeited TotalWarrantsForfeited	-0
CY2022	bkyi	Weighted Average Exercise Price Warrants Forfeited WeightedAverageExercisePriceWarrantsForfeited	0
CY2022	bkyi	Total Warrants Expired TotalWarrantsExpired	965
CY2022	bkyi	Weighted Average Exercise Price Warrants Expired WeightedAverageExercisePriceWarrantsExpired	518.4
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	270672
CY2022Q4	bkyi	Warrants Outstanding Exercise Price WarrantsOutstandingExercisePrice	104.95
CY2022	bkyi	Warrants Outstanding Weighted Average Remaining Life WarrantsOutstandingWeightedAverageRemainingLife	P2Y7M2D
CY2023	bkyi	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	2534148
CY2023	bkyi	Weighted Average Exercise Price Warrants Granted WeightedAverageExercisePriceWarrantsGranted	3.15
CY2023	bkyi	Total Warrants Exercised TotalWarrantsExercised	-177890
CY2023	bkyi	Weighted Average Exercise Price Warrants Exercised WeightedAverageExercisePriceWarrantsExercised	0.0018
CY2023	bkyi	Total Warrants Forfeited TotalWarrantsForfeited	-0
CY2023	bkyi	Weighted Average Exercise Price Warrants Forfeited WeightedAverageExercisePriceWarrantsForfeited	0
CY2023	bkyi	Total Warrants Expired TotalWarrantsExpired	438
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11843
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	299.61
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	-0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	530
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	311.11
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11313
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	299.07
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y25D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	151
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	94.44
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1896
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	256.3
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9266
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	311.16
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y11M15D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	9266
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	311.16
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P0Y11M15D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	9266
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	311.16
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y11M15D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q4	us-gaap	Share Price SharePrice	3
CY2022Q4	us-gaap	Share Price SharePrice	10.62
CY2021Q4	us-gaap	Share Price SharePrice	39.78
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	18310	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	100668	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-8521837	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11909903	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1175000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	122000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-175000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-20434	usd
CY2023	bkyi	Income Tax Expense Benefit Gross IncomeTaxExpenseBenefitGross	-134014	usd
CY2022	bkyi	Income Tax Expense Benefit Gross IncomeTaxExpenseBenefitGross	1276566	usd
CY2022	bkyi	Income Tax Expense Benefit Valuation Allowance IncomeTaxExpenseBenefitValuationAllowance	1297000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-134014	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-20434	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	112201	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	113000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	90405	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	169000	usd
CY2023Q4	bkyi	Deferred Tax Assets Resarch And Development Expenses DeferredTaxAssetsResarchAndDevelopmentExpenses	1017551	usd
CY2022Q4	bkyi	Deferred Tax Assets Resarch And Development Expenses DeferredTaxAssetsResarchAndDevelopmentExpenses	633000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	114251	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	114000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	32408	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	456000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	12353	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	19000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	150000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	828668	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	89000	usd
CY2023Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	0	usd
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	44000	usd
CY2023Q4	bkyi	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	0	usd
CY2022Q4	bkyi	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	44000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	1748235	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	0	usd
CY2023Q4	bkyi	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	206	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	44000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	13277118	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	15248000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17214690	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17188000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	170000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0141	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.009	pure
CY2023	bkyi	Effective Income Tax Reconciliation Permanent Differences EffectiveIncomeTaxReconciliationPermanentDifferences	0.0197	pure
CY2022	bkyi	Effective Income Tax Reconciliation Permanent Differences EffectiveIncomeTaxReconciliationPermanentDifferences	-0.047	pure
CY2023	bkyi	Effective Income Tax Rate Reconciliation Expiration Of Net Operating Loss And Research Credit Carryforwards Percent EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingLossAndResearchCreditCarryforwardsPercent	-0.0784	pure
CY2022	bkyi	Effective Income Tax Rate Reconciliation Expiration Of Net Operating Loss And Research Credit Carryforwards Percent EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingLossAndResearchCreditCarryforwardsPercent	-0.057	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.003	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0584	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.0105	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0908	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.005	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0024	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.109	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002	pure
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5949380	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2183767	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1928929	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1817108	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1320274	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1606111	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1476604	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	863493	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1913566
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2462203	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2078785	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1499218	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	3927815	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	2884098	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	1789213	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	7536084	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	5931330	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	4020339	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-118173695	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-120796573	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-122634397	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3756755	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1245091	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-485549	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9706057	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7983245	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	322818	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	340504	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1931732	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2143164	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1747376	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2621891	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2701345	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2306062	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1758398	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2378527	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1965558	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1688322	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2479878	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1838013	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1688322	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2479878	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1838013	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1688322	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2479878	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1838013	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1616176	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2459994	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1802649	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.04
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.45
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.22
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4112696	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5929804	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2926385	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4402989	usd
	us-gaap	Gross Profit GrossProfit	1186311	usd
	us-gaap	Gross Profit GrossProfit	1526815	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4074896	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5822272	usd
	us-gaap	Operating Expenses OperatingExpenses	5323237	usd
	us-gaap	Operating Expenses OperatingExpenses	7629298	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4136926	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6102483	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4168200	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6006212	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4311200	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6149023	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4311200	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-6149023	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4219170	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6021629	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.74
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-10.79

Files In Submission

Name	View Source	Status
0001437749-24-019357-index-headers.html	Edgar Link	pending
0001437749-24-019357-index.html	Edgar Link	pending
0001437749-24-019357.txt	Edgar Link	pending
0001437749-24-019357-xbrl.zip	Edgar Link	pending
bkyi-20231231.xsd	Edgar Link	pending
bkyi20231231_10k.htm	Edgar Link	pending
bush.jpg	Edgar Link	pending
ex_574538.htm	Edgar Link	pending
ex_574539.htm	Edgar Link	pending
ex_574541.htm	Edgar Link	pending
ex_574542.htm	Edgar Link	pending
ex_574543.htm	Edgar Link	pending
ex_574544.htm	Edgar Link	pending
ex_671869.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
bkyi-20231231_def.xml	Edgar Link	unprocessable
bkyi-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bkyi20231231_10k_htm.xml	Edgar Link	completed
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bkyi-20231231_cal.xml	Edgar Link	unprocessable
bkyi-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

2024 Q2 Form 10-K Financial Statement

#000143774924019357 Filed on June 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI BIO KEY INTERNATIONAL INC Stock $bkyi

2024 Q2 Form 10-K Financial Statement

#000143774924019357 Filed on June 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi